Heart Failure Beat: Equity in Heart Transplant - The Conversation Continues

The program's hosts, Michael Beasley, MD, and Priya Umapathi, MD, interview Nasrien Ibrahim, MD, the founder and executive director of the nonprofit The Equity in Heart Transplant Project, Inc. Priya discusses the ALT FLOW trial while Michael reviews a new scientific statement on Natriuretic Peptides from HFSA, JHFS, and ESC-HFA.

Equity in Heart Transplant - The Conversation Continues

The conversation around equity in care continues as our co-hosts interview Nasrien Ibrahim, MD, the founder and executive director of the nonprofit The Equity in Heart Transplant Project, Inc. about creative solutions for helping historically excluded and systemically oppressed patients become better candidates for transplant and other advanced heart failure therapies. On From Failure to Function, Priya discusses the ALT FLOW trial presented at THT 2023 that looks at using left atrial to coronary sinus shunting to treat symptomatic heart failure; and on HF Rounds Michael reviews the HFSA scientific statement, Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure.

Listen below and subscribe: Apple PodcastsGoogle Podcasts, SpotifyPodcast Home

Featuring

Hosts: 

  • Michael Beasley, MD, Assistant Professor of Medicine at the Yale New Haven Hospital @MHBeasleyMD

  • Priya Umapathi, MD, Assistant Professor in the Division of Cardiology & Advanced Heart Failure and Heart Transplant Cardiologist at Johns Hopkins Hospital @priyaumapathi

Guest: 

  • Nasrien Ibrahim, MD, Advanced Heart Failure and Transplant Cardiologist and one of the Commonwealth Fund Fellows in Minority Health Policy at Harvard University @DrNasrien